Javelin / Hospira Relationship Sours as Writs Fly
EP Vantage submits:Having unceremoniously dumped Myriad Pharmaceuticals (MYRX) in favor of Hospira (HSO), Javelin Pharmaceuticals (JAV) is now finding out just how painful relationships can be (Javelin infidelity leaves Myriad looking for another partner, April 13, 2010). Thursday, Javelin announced that it was suing its new merger partner after Hospira extended the deadline of its $145m tender offer for Javelin shares for the second time from June 2 to June 16. What might be forcing Javelin to take such drastic action is fear of the consequences if a deal does not go through. The group is almost certainly running on fumes when it comes to cash and desperately needs an additional $2m loan from Hospira that would have come as part of the end of the tender offer and was payable on June 1. Complete Story » seekingalpha.com |
Becoming a Living Donor
Signing up for a bone-marrow registry is simple and donating is relatively painless. And if the transplant succeeds, the results are astonishing. Here's what you need to consider. online.wsj.com |
Genzyme, Sanofi at Odds Over Threshold Price
Genzyme and France's Sanofi-Aventis are still talking about a takeover of the U.S. biotech firm, but they remain at odds about a price at which Sanofi could begin due diligence. online.wsj.com |
Practicing Patience at the Doctors' Office
Of all the problems with the health-care system, one of the most vexing for patients is sitting in the doctor's waiting room. It's the health-care equivalent of being stuck on the tarmac in a crowded plane. online.wsj.com |
LG Coaches Cook-off at NCAA(r) Bracket Town - Video
LG COACHES COOK-OFF DURING FINAL FOUR WEEKEND BENEFITS COACHES VS. CANCER feedproxy.google.com |